Hidden in Plain Sight: Identifying Women Living in the United States Who Could Benefit From HIV Preexposure Prophylaxis.
HIV preexposure prophylaxis (PrEP) with oral tenofovir/emtricitabine is an effective means of decreasing human immunodeficiency virus (HIV) acquisition among women. However, few women are prescribed and are taking PrEP. This article offers perspectives on barriers to use and strategies to increase uptake among women.
['Ojikutu|B O|BO|', 'Mayer|K H|KH|']
D000328:Adult D019380:Anti-HIV Agents D005260:Female D015658:HIV Infections D006801:Humans D065129:Pre-Exposure Prophylaxis D012307:Risk Factors D014481:United States
PrEP HIV and women pre-exposure prophylaxis